bluebird bio Announces August Investor Event
July 31 2020 - 08:00AM
Business Wire
bluebird bio, Inc. (NASDAQ: BLUE) today announced members of the
management team will participate in the Canaccord Genuity 40th
Annual Growth Conference, Wednesday, August 12, at 10:30 a.m.
ET.
To access the live webcast of bluebird bio’s presentation,
please visit the “Events & Presentations” page within the
Investors & Media section of the bluebird bio website at
http://investor.bluebirdbio.com. A replay of the webcast will be
available on the bluebird bio website for 90 days following the
event.
About bluebird bio, Inc.
bluebird bio is pioneering gene therapy with purpose. From our
Cambridge, Mass., headquarters, we’re developing gene therapies for
severe genetic diseases and cancer, with the goal that people
facing potentially fatal conditions with limited treatment options
can live their lives fully. Beyond our labs, we’re working to
positively disrupt the healthcare system to create access,
transparency and education so that gene therapy can become
available to all those who can benefit.
bluebird bio is a human company powered by human stories. We’re
putting our care and expertise to work across a spectrum of
disorders including cerebral adrenoleukodystrophy, sickle cell
disease, β-thalassemia and multiple myeloma, using three gene
therapy technologies: gene addition, cell therapy and
(megaTAL-enabled) gene editing.
bluebird bio has additional nests in Seattle, Wash.; Durham,
N.C.; and Zug, Switzerland. For more information, visit
bluebirdbio.com.
Follow bluebird bio on social media: @bluebirdbio, LinkedIn,
Instagram and YouTube.
bluebird bio is a trademark of bluebird bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200731005253/en/
Investors & Media Investors: Ingrid Goldberg,
410-960-5022 igoldberg@bluebirdbio.com OR Elizabeth Pingpank,
617-914-8736 epingpank@bluebirdbio.com Media: Jenn Snyder,
617-448-0281 jsnyder@bluebirdbio.com
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Feb 2024 to Mar 2024
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Mar 2023 to Mar 2024